Geneva, Jan. 12 -- International Clinical Trials Registry received information related to the study (ChiCTR2500114795) titled 'Development of an AI-Based Multimodal Model for the Diagnosis and Treatment of Metastatic Renal Cell Carcinoma' on Dec. 17, 2025.
Study Type: Observational study
Study Design:
Sequential
Primary Sponsor: Renji Hospital, Shanghai Jiaotong University School of Medicine
Condition:
Kidney Cancer
Recruitment Status: Not Recruiting
Phase: N/A
Date of First Enrollment: 2026-01-01
Target Sample Size: case series:25000;
Countries of Recruitment:
China
To know more, visit https://www.chictr.org.cn/showproj.html?proj=295309
Published by HT Digital Content Services with permission from Health Daily Digest....